Enlivex Therapeutics Ltd (ENLV) — Strategic Asset Allocation Index
Enlivex Therapeutics Ltd (ENLV) has a Strategic Asset Allocation Index of 32.3% as of June 2023. Strategic assets (PP&E of ILA14.31 Million plus long-term investments of ILA-) total ILA14.31 Million, measured against net assets of ILA44.34 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Enlivex Therapeutics Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Enlivex Therapeutics Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 32.3%, representing strategic assets of ILA14.31 Million against net assets of ILA44.34 Million ILA. Explore how efficiently does Enlivex Therapeutics Ltd generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Enlivex Therapeutics Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Enlivex Therapeutics Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ENLV company net worth.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 26.2% | ILA14.90 Million | ILA14.90 Million | ILA- | ILA56.84 Million | ▲ +23.2 pp |
| 2021 | 3.0% | ILA2.53 Million | ILA2.53 Million | ILA3.00K | ILA85.04 Million | ▼ -3.1 pp |
| 2020 | 6.0% | ILA2.14 Million | ILA2.14 Million | ILA0.00 | ILA35.49 Million | ▼ -3.3 pp |
| 2019 | 9.4% | ILA1.06 Million | ILA1.06 Million | ILA- | ILA11.28 Million | ▲ +2.3 pp |
| 2018 | 7.1% | ILA685.00K | ILA685.00K | ILA- | ILA9.71 Million | ▼ -5.2 pp |
| 2017 | 12.3% | ILA388.00K | ILA388.00K | ILA- | ILA3.16 Million | ▲ +8.7 pp |
| 2016 | 3.6% | ILA314.00K | ILA314.00K | ILA- | ILA8.70 Million | — |